Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan
An 84-year-old woman was admitted to our hospital with nonproductive cough and dyspnea on exertion. Computed tomography (CT) scan revealed extensive consolidation in the right lung. She was diagnosed with pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma using CT-guided lung biopsy. Her pu...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2013-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2013/675187 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567333648859136 |
|---|---|
| author | Shinobu Tamura Tokuji Ikeda Toshio Kurihara Yoshiteru Kakuno Hideki Nasu Yoshio Nakano Koichi Oshima Tokuzo Fujimoto |
| author_facet | Shinobu Tamura Tokuji Ikeda Toshio Kurihara Yoshiteru Kakuno Hideki Nasu Yoshio Nakano Koichi Oshima Tokuzo Fujimoto |
| author_sort | Shinobu Tamura |
| collection | DOAJ |
| description | An 84-year-old woman was admitted to our hospital with nonproductive cough and dyspnea on exertion. Computed tomography (CT) scan revealed extensive consolidation in the right lung. She was diagnosed with pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma using CT-guided lung biopsy. Her pulmonary images and respiratory symptoms did not improve two months after receiving 4 cycles of rituximab weekly; therefore, yttrium-90 ibritumomab tiuxetan was chosen as salvage therapy. The abnormal shadow on her pulmonary images was significantly reduced two months later, and she had no symptoms without nonhematological toxicities. She has had no progression for 18 months. Furthermore, radiation pneumonitis has not also been observed. We herein reported bulky pulmonary MALT lymphoma treated with yttrium-90 ibritumomab tiuxetan. |
| format | Article |
| id | doaj-art-c3240a7de0594f04970f6d1ddfda4bab |
| institution | Kabale University |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2013-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-c3240a7de0594f04970f6d1ddfda4bab2025-02-03T01:01:49ZengWileyCase Reports in Hematology2090-65602090-65792013-01-01201310.1155/2013/675187675187Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab TiuxetanShinobu Tamura0Tokuji Ikeda1Toshio Kurihara2Yoshiteru Kakuno3Hideki Nasu4Yoshio Nakano5Koichi Oshima6Tokuzo Fujimoto7Department of Internal Medicine, Social Insurance Kinan Hospital, 46-70 Shinjo, Tanabe, Wakayama 646-8588, JapanDepartment of Internal Medicine, Social Insurance Kinan Hospital, 46-70 Shinjo, Tanabe, Wakayama 646-8588, JapanDepartment of Pharmacy, Social Insurance Kinan Hospital, 46-70 Shinjo, Tanabe, Wakayama 646-8588, JapanDepartment of Radiology, Social Insurance Kinan Hospital, 46-70 Shinjo, Tanabe, Wakayama 646-8588, JapanDepartment of Internal Medicine, Social Insurance Kinan Hospital, 46-70 Shinjo, Tanabe, Wakayama 646-8588, JapanDepartment of Internal Medicine, Social Insurance Kinan Hospital, 46-70 Shinjo, Tanabe, Wakayama 646-8588, JapanDepartment of Pathology, School of Medicine, Kurume University, 67 Asahimati, Kurume 830-0011, JapanDepartment of Internal Medicine, Social Insurance Kinan Hospital, 46-70 Shinjo, Tanabe, Wakayama 646-8588, JapanAn 84-year-old woman was admitted to our hospital with nonproductive cough and dyspnea on exertion. Computed tomography (CT) scan revealed extensive consolidation in the right lung. She was diagnosed with pulmonary mucosa-associated lymphoid tissue (MALT) lymphoma using CT-guided lung biopsy. Her pulmonary images and respiratory symptoms did not improve two months after receiving 4 cycles of rituximab weekly; therefore, yttrium-90 ibritumomab tiuxetan was chosen as salvage therapy. The abnormal shadow on her pulmonary images was significantly reduced two months later, and she had no symptoms without nonhematological toxicities. She has had no progression for 18 months. Furthermore, radiation pneumonitis has not also been observed. We herein reported bulky pulmonary MALT lymphoma treated with yttrium-90 ibritumomab tiuxetan.http://dx.doi.org/10.1155/2013/675187 |
| spellingShingle | Shinobu Tamura Tokuji Ikeda Toshio Kurihara Yoshiteru Kakuno Hideki Nasu Yoshio Nakano Koichi Oshima Tokuzo Fujimoto Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan Case Reports in Hematology |
| title | Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan |
| title_full | Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan |
| title_fullStr | Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan |
| title_full_unstemmed | Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan |
| title_short | Bulky Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma Treated with Yttrium-90 Ibritumomab Tiuxetan |
| title_sort | bulky pulmonary mucosa associated lymphoid tissue lymphoma treated with yttrium 90 ibritumomab tiuxetan |
| url | http://dx.doi.org/10.1155/2013/675187 |
| work_keys_str_mv | AT shinobutamura bulkypulmonarymucosaassociatedlymphoidtissuelymphomatreatedwithyttrium90ibritumomabtiuxetan AT tokujiikeda bulkypulmonarymucosaassociatedlymphoidtissuelymphomatreatedwithyttrium90ibritumomabtiuxetan AT toshiokurihara bulkypulmonarymucosaassociatedlymphoidtissuelymphomatreatedwithyttrium90ibritumomabtiuxetan AT yoshiterukakuno bulkypulmonarymucosaassociatedlymphoidtissuelymphomatreatedwithyttrium90ibritumomabtiuxetan AT hidekinasu bulkypulmonarymucosaassociatedlymphoidtissuelymphomatreatedwithyttrium90ibritumomabtiuxetan AT yoshionakano bulkypulmonarymucosaassociatedlymphoidtissuelymphomatreatedwithyttrium90ibritumomabtiuxetan AT koichioshima bulkypulmonarymucosaassociatedlymphoidtissuelymphomatreatedwithyttrium90ibritumomabtiuxetan AT tokuzofujimoto bulkypulmonarymucosaassociatedlymphoidtissuelymphomatreatedwithyttrium90ibritumomabtiuxetan |